DES PLAINES, Ill., Feb. 2, 2023 /PRNewswire/ -- Americaneagle.com, a family-owned, global digital agency, and ImmunoProfile, a medical diagnostics company, are proud to jointly announce the launch of ...
BRYAN, Texas, April 04, 2023 (GLOBE NEWSWIRE) -- iBio, Inc. (IBIO) (“iBio” or the “Company”), an AI-driven innovator of precision antibody immunotherapies, announced that a presentation given today by ...
News-Medical.Net on MSN
COVID-19 immunity stays specific and barely boosts protection against common cold coronaviruses
This study shows that SARS-CoV-2 infection and vaccination generate strong, highly specific spike-binding immune responses ...
Scientists have recently revealed that memory T cell responses to common cold coronaviruses stably persist for a long time. Such responses are associated with a high level of pre-existing immunity ...
A new study asks how long SARS-CoV-2 antibodies stay in the body and whether antibodies to coronaviruses that cause the common cold might also keep SARS-CoV-2 at bay. Image credit: Gary Hershorn/Getty ...
HAMILTON, ON and BOSTON, June 14, 2022 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as ...
The current generation of monoclonal antibodies is ineffective against the predominant variants of SARS-CoV-2 in circulation. Recent studies by Callaway et al. open the possibility that a new type of ...
To assess the durability of SARS-CoV-2 antibodies and to test the hypothesis that a previous common cold infection may protect against COVID-19, Dr. Moncunill — along with Prof. Carlota Dobaño, head ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback